Jordi C Ochando
Overview
Explore the profile of Jordi C Ochando including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
1567
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang R, Fang H, Chen R, Ochando J, Ding Y, Xu J
Transplantation
. 2018 Sep;
102(12):e483-e493.
PMID: 30211827
Background: Airway epithelium is the primary target of trachea and lung transplant rejection, the degree of epithelial injury is closely correlated with obliterative bronchiolitis development. In this study, we investigated...
2.
Heymann F, Peusquens J, Ludwig-Portugall I, Kohlhepp M, Ergen C, Niemietz P, et al.
Hepatology
. 2015 Mar;
62(1):279-91.
PMID: 25810240
Unlabelled: The liver is essential for inducing immunological tolerance toward harmless antigens to maintain immune system homeostasis. However, the precise cellular mechanisms of tolerance induction against particle-bound antigens, the role...
3.
Chen L, He Z, Slinger E, Bongers G, Lapenda T, Pacer M, et al.
Mucosal Immunol
. 2014 Aug;
8(2):390-402.
PMID: 25160819
Interleukin-23 (IL-23) responsive group 3 innate lymphoid cells (ILC3s) have been implicated in immune homeostasis and pathogenesis in the adult, but little is known about their roles in the newborn....
4.
Ugel S, Peranzoni E, Desantis G, Chioda M, Walter S, Weinschenk T, et al.
Cell Rep
. 2012 Sep;
2(3):628-39.
PMID: 22959433
Peripheral tolerance to tumor antigens (Ags) is a major hurdle for antitumor immunity. Draining lymph nodes are considered the privileged sites for Ag presentation to T cells and for the...
5.
Ochando J, Chen S
Immunol Res
. 2012 Apr;
54(1-3):275-85.
PMID: 22535241
Myeloid-derived suppressor cells (MDSC) are myeloid cells that suppress the immune response, a definition that reflects both their origin and their function. As negative regulators of the immune response, MDSC...
6.
Hashimoto D, Chow A, Greter M, Saenger Y, Kwan W, Leboeuf M, et al.
J Exp Med
. 2011 May;
208(5):1069-82.
PMID: 21536742
Acute graft-versus-host disease (GVHD) results from the attack of host tissues by donor allogeneic T cells and is the most serious limitation of allogeneic hematopoietic cell transplantation (allo-HCT). Host antigen-presenting...
7.
Gehrie E, van der Touw W, Bromberg J, Ochando J
Methods Mol Biol
. 2010 Oct;
677:127-47.
PMID: 20941607
Dendritic cells (DC) are professional antigen-presenting cells (APCs) that modulate the outcome of the immune response toward immunity or tolerance. There are a large variety of DC subsets according to...
8.
Boros P, Ochando J, Chen S, Bromberg J
Hum Immunol
. 2010 Aug;
71(11):1061-6.
PMID: 20705113
Myeloid derived suppressor cells (MDSC) contribute to the negative regulation of immune response in cancer patients. This review summarizes results on important issues related to MDSC biology, including expansion and...
9.
Rodriguez-Garcia M, Boros P, Bromberg J, Ochando J
Curr Opin Organ Transplant
. 2010 Jul;
15(4):416-21.
PMID: 20616727
Purpose Of Review: Understanding the interplay between myeloid dendritic cells and T cells under tolerogenic conditions, and whether their interactions induce the development of antigen-specific regulatory T cells (Tregs) is...
10.
Garcia M, Ledgerwood L, Yang Y, Xu J, Lal G, Burrell B, et al.
J Clin Invest
. 2010 Jun;
120(7):2486-96.
PMID: 20551515
One of the main unresolved questions in solid organ transplantation is how to establish indefinite graft survival that is free from long-term treatment with immunosuppressive drugs and chronic rejection (i.e.,...